Clinical Trial

Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA

Name: Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA — clinical trial record (NCT06591390)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

Trial Details

NCT Number	NCT06591390
Lead Sponsor	Kafrelsheikh University
Conditions	Ischemic Stroke
Enrollment	900 participants
Start Date	2022-02-09
Primary Completion	2024-09-15 (estimated)
Study Completion	2024-10-01 (estimated)
Updated on ClinicalTrials.gov	2024-09-19